Safety and efficacy of pembrolizumab monotherapy in patients with previously treated advanced gastric and gastroesophageal junction cancer: phase 2 clinical KEYNOTE‑059 trial - Fuchs, C S; Doi, T; Jang, R W (JAMA Oncol, 2018)
. doi:10.1001/jamaoncol.2018.0013